FADD Phosphorylation Regulates Lipolysis and Metabolism
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods fail to effectively regulate lipolysis and fatty acid oxidation metabolism, leading to obesity and related metabolic disorders, as they lack targeted regulation of key enzymes and transcription factors involved in triglyceride breakdown and fatty acid oxidation.
Innovation Solution
A method involving the regulation of Fas-related death domain protein phosphorylation to increase the activity of hormone-sensitive lipase (HSL) and peroxisome proliferator-activated receptor alpha (PPARα), along with other enzymes involved in fatty acid β-oxidation, to enhance lipolysis and fatty acid oxidation rates.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional methods are used to regulate lipolysis and fatty acid oxidation, then general metabolic control is maintained, but targeted regulation of key enzymes (HSL, PPARα) and transcription factors is insufficient, leading to ineffective treatment of obesity and metabolic disorders
Solution Approach 1:
The patent uses FADD protein as an intermediary molecule that connects upstream signaling pathways to downstream lipolytic enzymes (HSL, ATGL) and transcription factors (PPARα). By regulating FADD phosphorylation status, the system achieves coordinated control of multiple metabolic targets through a single regulatory node, improving reliability while managing complexity
Solution Approach 2:
The patent employs phosphorylation parameter changes of FADD protein (specifically at serine 194) to switch between inactive and active states. This post-translational modification parameter change enables precise control of lipolysis and fatty acid oxidation rates by modulating FADD's ability to interact with and activate downstream targets HSL, ATGL, and PPARα
2Quantity of substance
If lipolysis activity is decreased to maintain energy storage, then triglyceride accumulation in adipose tissue increases, but excessive lipolysis leads to lipodystrophy syndrome and ectopic triglyceride storage
Solution Approach 1:
The patent implements a feedback regulation mechanism where FADD phosphorylation status responds to cellular energy state and hormonal signals, dynamically adjusting the activity of HSL and PPARα. This feedback control ensures lipolysis rates remain within physiological ranges, preventing both excessive fat storage and harmful ectopic lipid deposition that characterize lipodystrophy
Solution Approach 2:
The patent achieves spatially selective regulation by localizing FADD phosphorylation effects to specific adipose tissue compartments. By controlling FADD-mediated signaling in white adipose tissue versus brown adipose tissue and muscle, the system maintains appropriate triglyceride storage in safe depots while preventing ectopic storage in harmful locations
3Productivity
If HSL activity is increased to enhance triglyceride hydrolysis, then lipolysis rate improves, but without coordinated regulation of PPARα and β-oxidation enzymes, fatty acid oxidation efficiency remains insufficient
Solution Approach 1:
The patent merges the regulation of HSL (lipolytic enzyme) and PPARα (transcription factor for β-oxidation enzymes) under a single FADD-mediated control mechanism. This coordinated activation ensures that increased triglyceride hydrolysis is matched by proportional increases in fatty acid oxidation capacity, maintaining metabolic efficiency and preventing energy loss
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach improves lipolysis and fatty acid oxidation rates, reducing body fat content and weight, effectively treating obesity and related metabolic syndromes by increasing the phosphorylation of FADD protein and its downstream targets.
Implementation Method 1
increasing the phosphorylation of FADD protein and its downstream targets
Implementation Method 2
The lipolysis of triglycerides is catalyzed by at least three enzymes: adipocyte triglyceride (ATGL) that mainly catalyzes the hydrolysis of the first ester bond of the triglyceride, and the resulting diacylglycerol is catalyzed by hormone sensitive esterase (HSL) to produce monoacylglycerols
Implementation Method 3
adipocyte triglyceride (ATGL) that mainly catalyzes the hydrolysis of the first ester bond of the triglyceride
Implementation Method 4
the resulting diacylglycerol is catalyzed by hormone sensitive esterase (HSL) to produce monoacylglycerols
Implementation Method 5
monoacylglycerols are catalyzed by monoacylglycerol esterase (MGL)
Implementation Method 6
The decomposition of fatty acids is carried out in the form of oxidation, and the modes of oxidation include α-oxidation, β-oxidation and ω-oxidation, of which β-oxidation is the primary mode
Data Source
AI summary
Provided are a method for promoting the lipolysis and fatty acid oxidative metabolism in mammals or cells derived from mammals, a method for downregulating the fat content and the weight of a mammalian body, as well as a method for increasing the intracellular cAMP concentration, increasing the phosphorylation degree and the activity of the hormone-sensitive esterase HSL, enhancing the transcription activity of PPAR alpha and increasing the activities of enzymes involved in a fatty acid beta oxidation process. By simulating the expression of a protein corresponding to a gene responsible for the phosphorylation of the Fas-associated death domain protein, or treating and acting on mammals or cells derived from mammals with a material that can increase the phosphorylation degree of the Fas-associated death domain protein, said methods increases the phosphorylation of the Fas-associated death domain protein.